Federal Court Decisions

Decision Information

Decision Content

     T-2792-96

B E T W E E N :

     MERCK & CO., INC., MERCK FROSST CANADA INC.

     ZENECA LIMITED and ZENECA PHARMA INC.

     Plaintiffs

     - and -

     APOTEX INC.

     Defendant

     REASONS FOR ORDER

ROTHSTEIN J.:

     Apotex moves to strike out the Statement of Claim.

     Paragraphs 14 to 17 of the Statement of Claim refer to current alleged infringement. They are satisfactory and will not be struck out.

     According to the submissions of counsel for the Plaintiffs, paragraphs 18, 19 and 20 of the Plaintiffs' pleading refer to the threat by Apotex of infringement approximately one year from now. The basis is that the Plaintiffs have written to Apotex asking if it will infringe in the future. Apotex has not responded. This is the basis of the threat which the Plaintiffs plead. The Plaintiffs have provided some further particulars by way of a letter but the letter adds nothing to what is already known.

     I think these paragraphs must be struck out for two reasons. First, the pleadings are only intended to enable the plaintiffs to get to discovery to bootstrap their claim; while discovery is for the purpose of obtaining admissions from the other party and ascertaining the position of the other party, it is not a fishing expedition simpliciter, which is what it would be used for here. Second, the threat, even if it could be substantiated, is approximately one year away according to Plaintiffs' counsel. At best, these paragraphs are premature. Paragraphs 18, 19 and 20 are struck out.

     The Plaintiffs are authorized to amend paragraph 17 to have it read that Apotex has offered for sale and has sold APO-LISINOPRIL in Canada.

     Costs to the Defendant in the sum of one thousand dollars inclusive of disbursements in any event of the cause.

     "Marshall E. Rothstein"

                                     Judge

Toronto, Ontario

March 21, 1997

     FEDERAL COURT OF CANADA

     Names of Counsel and Solicitors of Record

COURT NO:                  T-2792-96

STYLE OF CAUSE:          MERCK FROSST CANADA INC.,

                     and MERCK & CO., INC., ZENECA LIMITED and ZENECA PHARMA INC.

                     - and -

                     APOTEX INC.

                    

DATE OF HEARING:          MARCH 21, 1997

PLACE OF HEARING:          TORONTO, ONTARIO

REASONS FOR ORDER BY:      ROTHSTEIN, J.

DATED:                  MARCH 21, 1997

APPEARANCES:

                     Mr. Gunars A. Gaikis, Ms. McVean

                          For the Plaintiffs

                     Mr. David Scrimger

                         For the Defendant

SOLICITORS OF RECORD:

                     A. David Morrow, Gunars A. Gaikis

                     SMART & BIGGAR

                     Barristers and Solicitors

                     439 University Avenue, Ste. 2300

                     Toronto, Ontario

                     M5G 1Y8

                         For the Plaintiffs

                      H.B. Radomski, David Scrimger

                     Goodman Phillips & Vineberg

                     Barristers and Solicitors

                     Suite 2400, Box 24

                     250 Yonge Street             

                     Toronto, Ontario

                     M5B 2M6

                         For the Defendant

                     FEDERAL COURT OF CANADA

                     Court No.:      T-2792-96

                     Between:

                     MERCK & CO., INC., MERCK
                     FROSST      CANADA INC., ZENECA
                     LIMTIED and ZENECA PHARMA INC.

     Plaintiffs

                     - and -

                     APOTEX INC.

     Defendant

                     REASONS FOR ORDER


 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.